BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX, Inc., the leader in NGS-based gene fusion detection, has announced an agreement with GenomOncology, Inc., the leader in NGS variant interpretation, to ...
Sanger sequencing and real-time PCR methods have been the standard molecular methods in clinical diagnostics for decades. Deep sequencing or Next Generation Sequencing (NGS) technology revolutionized ...
CAMBRIDGE, England--(BUSINESS WIRE)--Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has been awarded the second stage of a contract to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback